References
- Stoll BJ, Kleigman RM. Jaundice and hyperbilirubinemia in the newborn. Nelson textbook of pediatrics. Philadelphia (PA): WB Saunders; 2004. p. 592–596.
- Wei CC, Chang CH, Lin CL, et al. Neonatal jaundice and increased risk of attention-deficit hyperactivity disorder: a population-based cohort study. J Child Psychol Psychiatry Allied Disciplines. 2015;56:460–467.
- Stevenson DK, Bhutani VK. Preterm neonates: beyond the guidelines for neonatal hyperbilirubinemia. Clin Perinatol. 2016;43:xvii–xviii.
- Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140:396–403.
- Watchko JF. Bilirubin-induced neurotoxicity in the preterm neonate. Clin Perinatol. 2016;43:297–311.
- Bhutani VK, Wong RJ, Stevenson DK. Hyperbilirubi-nemia in preterm neonates. Clin Perinatol. 2016;43:215–232.
- Kawade N, Onishi S. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem J. 1981;196:257–260.
- Armanian AM, Barekatain B, Hoseinzadeh M, et al. Prebiotics for the management of hyperbilirubinemia in preterm neonates. J Matern-Fetal Neonat Med. 2016;29:3009–3013.
- Mohammadzadeh AKF, Ramezani M. Prophylactic effect of zinc sulphate on hyperbilirubinemia in premature very low birth weight neonates: a randomized clinical trial. Iran J Neonatol – IJN. 2015;5:6–10.
- Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. Semin Neonatol. 2002;7:111–119.
- Ramy N, Ghany EA, Alsharany W, et al. Jaundice, phototherapy and DNA damage in full-term neonates. J Perinatol. 2016;36:132–136.
- Mendez-Sanchez N, Roldan-Valadez E, Flores MA, et al. Zinc salts precipitate unconjugated bilirubin in vitro and inhibit enterohepatic cycling of bilirubin in hamsters. Eur J Clin Investig. 2001;31:773–780.
- Kumar A, Bagri NK, Basu S, et al. Zinc supplementation for neonatal hyperbilirubinemia: a randomized controlled trial. Indian Pediatr. 2014;51:375–378.
- Rana N, Mishra S, Bhatnagar S, et al. Efficacy of zinc in reducing hyperbilirubinemia among at-risk neonates: a randomized, double-blind, placebo-controlled trial. Indian J Pediatr. 2011;78:1073–1078.
- Patton DRSA. Effect of oral zinc on hyperbilirubinemia in full term neonates. Paediatr Indones. 2011;51:107–110.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
- Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from: www.cochrane-handbook.org
- Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
- Maamouri G, Boskabadi H, Mafinejad S, et al. Efficacy of oral zinc sulfate intake in prevention of neonatal jaundice. Iran J Neonatol: IJN. 2013;4:11–16.
- Mishra S, Cheema A, Agarwal R, et al. Oral zinc for the prevention of hyperbilirubinaemia in neonates. Cochrane Database Syst Rev. 2015;CD008432.
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.